Mechanism of Action: Cytochrome P450 1A1 Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 1A1 Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 077844-001 | Dec 17, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cipla | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 078119-001 | Nov 21, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hetero Labs Ltd Iii | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 091560-001 | Sep 13, 2013 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Pharms Inc | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 091294-001 | Jun 18, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Strides Pharma | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 091050-001 | Oct 28, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma Ltd | ABACAVIR SULFATE | abacavir sulfate | SOLUTION;ORAL | 077950-001 | Mar 14, 2018 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
